The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...
Asıl Yazarlar: | Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
F1000Research
2021
|
Benzer Materyaller
-
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
Yazar:: Rachel Tanner, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01) -
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Yazar:: Rachel Tanner, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
Yazar:: Pepponi, I, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
Yazar:: Brennan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)